Atlas Trials

ERBB2 Gene Amplification

5 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ERBB2 Gene Amplification

RecordFirmDate
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery (NCT03365882)SWOG Cancer Research Network2017-11-27
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation (NCT03065387)M.D. Anderson Cancer Center2017-10-31
Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric Cancer (NCT02004769)Sun Yat-sen University2013-11-01
Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer (NCT00006089)National Cancer Institute (NCI)2000-09-18

Track ERBB2 Gene Amplification automatically

Every clearance here is in the API, with alerts when new ones post.